2m 2m 2m 2m 2m 2m 2m
TURN THERAPEUTIC (TTRX)
NASDAQ
$9.28-$0.18 (-1.87%)
Price as of Aug 24, 2026 9:54 AM EDT- $287.3MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
TURN THERAPEUTIC (TTRX)
$9.28-$0.18 (-1.87%)
TTRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $9.46 | ||
Change | -$0.08 (-0.84%) | ||
Open | $9.63 | ||
High | $9.93 | ||
Low | $9.35 | ||
Previous Close | $9.54 | ||
Volume | 22,225 | ||
30-Day Average Volume | 56,060 | ||
1-Week Change | -1.15% | ||
1-Month Change | -7.07% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 30.4M | ||
Total Assets | $17.0M | ||
Market Cap | $287.3M | ||
Enterprise Value | $283.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$5.8M | ||
Free Cash Flow | -$923,364.00 | ||
EBIT | -$5.6M | ||
EBITDA | -$5.6M | ||
Net Working Capital | $1.7M | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | -51 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -47 | ||
PEG | 0 | ||
Price/Free Cash Flow | -311 | ||
Price/Operating Cash Flow | -311 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue